소분자 제약

 
 
정보 요청

고품질 제품 및 서비스


신약개발은 복잡하고 도전적인 과정입니다. 화학 및 제약 산업을 위한 고품질 제품과 서비스의 선도자로서, 머크 밀리포아는 개발을 최적화하고 시판까지의 시간을 줄이기 위해 필요한 모든 것을 제공합니다.

또한 종합적인 엠프루브 도시어(EMPROVE® dossiers)를 이용하여, 머크 밀리포아는 성장 추세에 있는 의약품 원료물질에 대해 상세하고 사용에 특화된 문서를 제공하여 향상된 안전성뿐만 아니라 상당한 시간 및 비용 절약을 도모합니다.
  • 진화하는 시장 및 규제 요구사항을 위해 끊임없이 업데이트되는 포트폴리오
  • 광범위한 고객 중심 서비스
  • 국제적 규모의 맞춤형 제작 수량
  • 모든 일반 화학반응의 95% 이상을 가능하게 하는 능력의 생산 기술이 증명하는 전문성과 최신 장비
  • 화학뿐만 아니라 규제 분야에서 고객님을 지원하는 통합 개발 체인을 통한 완벽한 서비스
  • cGMP 인증과 FDA 검사를 받은 개발 및 생산 현장

보도 자료

18-4월-2018
Merck Wins INTERPHEX Exhibitor Award for Best Technological Innovation

Merck today announced that its Millistak+® HC Pro portfolio has won an INTERPHEX Exhibitor Award for Best Technological Innovation.

20180418 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
17-4월-2018
Merck Introduces New Single-use Technologies to Advance Flexible Manufacturing

Merck today introduced three new products to support flexible manufacturing of biologics.

20180417
12-4월-2018
Merck Helps Accelerate Global Access to Affordable Vaccines

Merck today announced a partnership with Oxford University’s Jenner Institute to develop more robust and scalable vaccine manufacturing processes.

20180412 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
28-3월-2018
Merck Named Best Bioprocessing Supplier in Asia

Merck was named the overall “Best Bioprocessing Supplier” and won the sub-category of “Best Bioprocessing Supplier Award for Single-use Systems” at the Asia-Pacific Bioprocessing Excellence Awards 2018 ceremony.

20180328 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
05-3월-2018
Merck and Schneider Electric Sign MoU to Advance China’s Biopharmaceutical Industry

Merck and Schneider Electric, a global specialist in energy management and automation, today announced the signing of a Memorandum of Understanding (MoU) that aims to automate the mAb process for China’s biopharmaceutical industry.

20180305 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
27-2월-2018
Merck Announces €300,000 in Grants to Accelerate Therapeutic Research in Life Science

Merck today announced the recipients of its Emerging Biotech Grant Program in China.

20180227 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
26-2월-2018
MilliporeSigma Announces 2018 North American Curiosity Cube™ Mobile Science Lab Tour

MilliporeSigma today announced plans for its second annual Curiosity Cube™ mobile science lab tour, which will kick off in February and visit more than 100 communities in the U.S. and Canada.

20180226 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
22-2월-2018
Merck Announces Investment in India with New Life Science Manufacturing & Distribution Centre

Merck today announced that it will invest €16.6 million in its new manufacturing and distribution centre for the Life Science business, located near Mumbai, India.

20180222 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
22-2월-2018
Merck Signs Agreement with Incheon Free Economic Zone to Build Cell Culture Facility in South Korea

Merck today announced it has signed an agreement with Incheon Free Economic Zone (IFEZ) to build an integrated cell culture facility in Songdo, Incheon.

20180222 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
22-2월-2018
Merck Accelerates Mobius® Single-Use Manufacturing in Wuxi

Merck today announced an additional investment to accelerate Mobius® single-use manufacturing in Wuxi, China.

20180222 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
20-2월-2018
Merck Receives Two More Patents for CRISPR Technology

Merck today announced that the Korean Intellectual Property Office and the Israel Patent Office have each issued notices granting Merck’s patent applications for the company’s CRISPR technology.

20180220 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
13-2월-2018
Merck Launches Viresolve® Barrier Capsule Filters to Protect Against Bioreactor Contamination

Merck today introduced Viresolve® Barrier capsule filters to reduce the risk of bioreactor contamination.

20180213 Small Molecule Pharmaceuticals,Biopharmaceutical Manufacturing
전체 뉴스 보기
 
Webinar:  API Stability in Solid Dose Formulation – the Myth of Inert Excipients

Webinar:
API Stability in Solid Dose Formulation – the Myth of Inert Excipients

Register Now
Successful Drug Development with Synthetic Lipids: Critical Aspects and Strategies

Webinar:
Successful Drug Development with Synthetic Lipids:
Critical Aspects and
Strategies

Watch Now
Webinar: Smart Labels - Digital Innovation by Raw Material Suppliers to Support Drug Manufacturers’ Processes

Webinar:
Smart Labels – Digital Innovation by Raw Material Suppliers to Support Drug Manufacturers’ Processes

Watch Now
Explore, Learn, Collaborate: M Lab® Collaboration Centers - Take a tour!

이벤트